Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-216-2 | CAS number: 93-08-3
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Bacterial reverse mutation test:
An in vitro gene mutation study in bacteria according to OECD 471 and GLP with the registered substance (CAS 93-08-3) is ongoing. Test results will be submitted after receiving the final study report.
In vitro mammalian cell chromosome aberration test:
An in vitro cytogenicity study according to OECD 473 and GLP with the registered substance (CAS 93-08-3) is ongoing.Test results will be submitted after receiving the final study report.
In vitro gene mutation test in mammalian cell:
An in vitro gene mutation study in mammalian cells according to OECD 476 and GLP with the registered substance (CAS 93-08-3) is ongoing.Test results will be submitted after receiving the final study report.
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Data waiving:
- other justification
- Justification for data waiving:
- other:
- Justification for type of information:
- This information will be submitted later based on the ECHA communication number CCH-D-2114501340-71-01/F.
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Data waiving:
- other justification
- Justification for data waiving:
- other:
- Justification for type of information:
- This information will be submitted later based on the ECHA communication number CCH-D-2114501340-71-01/F.
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Data waiving:
- other justification
- Justification for data waiving:
- other:
- Justification for type of information:
- This information will be submitted later based on the ECHA communication number CCH-D-2114501340-71-01/F.
Referenceopen allclose all
Endpoint conclusion
- Endpoint conclusion:
- no study available
Genetic toxicity in vivo
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
Justification for classification or non-classification
In vitro gene mutation studies in bacterial and mammalian cells according to OECD 471 and OECD 476 are ongoing with the registered substance (CAS 93-08-3). Also, an in vitro cytogenicity study according to OECD 473 with the registered substance (CAS 93-08-3) is running. Hence, justification for classification or non-classification will be added upon receiveng these test results.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
